Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kinase inhibitor research and innovative clinical collaborations.
197 employees · est. 2000
Ambit is the older company (2000 vs 2003); Deciphera Pharmaceuticals is the larger of the two.
Side-by-Side Comparison
| Metric | Ambit | Deciphera Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2003 |
| Headquarters | ||
| Headquarters | Not tracked yet | Waltham, United States |
| Employees | ||
| Employees | 197 | 526 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series Unknown | Acquired |
| Total Funding | ||
| Total Funding | $215.73M | $3.54B |
| Funding Rounds | ||
| Funding Rounds | 10 | 10 |
| Services | ||
| Services | Not tracked yet | Design and Development of Kinase Inhibitors, Clinical Trials and Studies, Expanded Access Program, Patient Response Improvement Programs |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Cancer, Healthcare Professionals, Pharmaceutical Partners, Clinical Researchers |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Kinase Inhibitors, Cancer Treatment, Inflammatory Disease, Clinical Trials, FLT3 Inhibitor, Oncology, Astellas Pharma Inc., Small Molecule Drugs, AC220, AC480, AC430, JAK2 Inhibitor, Preclinical Pipeline, Drug Discovery | Biopharmaceutical, Cancer Treatment, Medicines Development, Switch-control Kinase Inhibitors, Kinase Biology, Drug Discovery, Oncology, Innovation In Medicine, Pharmaceutical Research, Tumor Treatment, Biotech Innovation, Kinase Inhibitor Platform |
| Website | ||
| Website | ambitbio.com | deciphera.com |
About Ambit
Ambit Biosciences is a biopharmaceutical company founded in 2000 with a focus on discovering and developing small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other conditions. The company's lead compound, AC220, is a highly selective FMS-like tyrosine kinase-3 (...
About Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, under the slogan A member of ONO Group, is a noteworthy player in the biopharmaceutical sector, dedicated to innovating crucial cancer treatments. Established in 2003, the company leverages a proprietary switch-control kinase inhibitor platform that capitalizes on extensiv...
We will tell you when either one moves
BounceWatch watches Ambit and Deciphera Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ambit and Deciphera Pharmaceutic... — by email.
Frequently Asked Questions
Compare Ambit with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ambit on 12 Sep 2024, and Deciphera Pharmaceuticals on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.